Sangrix Inc. (SGRX)
NASDAQ: SGRX · Real-Time Price · USD
2.100
-0.110 (-4.98%)
At close: Sep 4, 2026, 4:00 PM EDT
1.970
-0.130 (-6.19%)
After-hours: Sep 4, 2026, 6:21 PM EDT
Sangrix Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 0.04 | 0.04 | 2.89 | 6.26 | 0.19 | - | |
Revenue Growth | - | -98.63% | -53.87% | 3155.03% | - | - |
Cost of Revenue | - | - | 3.83 | 10.83 | 0.4 | - |
Gross Profit | 0.04 | 0.04 | -0.95 | -4.57 | -0.21 | - |
Selling, General & Admin | 2.11 | 3.08 | 3.82 | 2.91 | 4.23 | 1.59 |
Other Operating Expenses | 7.73 | - | 0.01 | 0.18 | 0.05 | - |
Operating Expenses | 9.86 | 3.03 | 5.03 | 6.44 | 5.9 | 3.47 |
Operating Income | -9.82 | -2.99 | -5.97 | -11 | -6.11 | -3.47 |
Interest Expense | -0.6 | -0.46 | -0.5 | -0.23 | -0.05 | -0.16 |
Other Non Operating Income (Expenses) | -2.21 | -0.92 | -2.95 | 0.32 | -0 | -0.13 |
EBT Excluding Unusual Items | -12.63 | -4.37 | -9.42 | -10.91 | -6.17 | -3.77 |
Gain (Loss) on Sale of Investments | - | - | -2.39 | -0.61 | - | - |
Asset Writedown | - | - | -6.47 | -16.69 | - | - |
Other Unusual Items | -9.43 | -2.15 | - | - | 0.82 | 0.13 |
Pretax Income | -22.05 | -6.52 | -18.28 | -28.22 | -5.34 | -3.64 |
Earnings From Continuing Operations | -22.05 | -6.52 | -18.28 | -28.22 | -5.34 | -3.64 |
Earnings From Discontinued Operations | - | - | - | - | 8.58 | -41.97 |
Net Income to Company | -22.05 | -6.52 | -18.28 | -28.22 | 3.24 | -45.61 |
Minority Interest in Earnings | -0.06 | -0.02 | 0.75 | - | - | - |
Net Income | -22.11 | -6.53 | -17.53 | -28.22 | 3.24 | -45.61 |
Net Income to Common | -22.11 | -6.53 | -17.53 | -28.22 | 3.24 | -45.61 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | - | - |
Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | - | - |
Shares Change | 698.41% | 340.80% | 59.85% | - | - | - |
EPS (Basic) | -109.86 | -84.84 | -1003.41 | -2581.55 | - | - |
EPS (Diluted) | -109.86 | -84.84 | -1003.41 | -2581.55 | - | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -1.45 | -2.29 | -7.93 | -6.88 | -22.54 | -10.39 |
Free Cash Flow Per Share | -7.22 | -29.74 | -453.82 | -629.15 | - | - |
Gross Margin | 100.00% | 100.00% | -32.72% | -72.92% | -109.71% | - |
Operating Margin | -24865.89% | -7574.86% | -206.82% | -175.73% | -3175.82% | - |
Profit Margin | -55986.51% | -16543.83% | -606.95% | -450.66% | 1684.10% | - |
Free Cash Flow Margin | -3678.96% | -5799.74% | -274.51% | -109.83% | -11717.24% | - |
EBITDA | - | -2.09 | -5.07 | -5.64 | -5.83 | -3.47 |
EBITDA Margin | - | - | -175.63% | -90.09% | - | - |
D&A For EBITDA | - | 0.9 | 0.9 | 5.36 | 0.28 | 0.01 |
EBIT | -9.82 | -2.99 | -5.97 | -11 | -6.11 | -3.47 |
EBIT Margin | - | - | -206.82% | -175.73% | - | - |
Revenue as Reported | 0.04 | 0.04 | 2.89 | 6.26 | 0.19 | - |